SILENCE THERAPEUTICS PLC-ADR (SLN)
US82686Q1013 - ADR
ChartMill assigns a Buy % Consensus number of 85% to SLN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 39.35. This target is 471.97% above the current price.
SLN was analyzed by 12 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about SLN.
In the previous month the buy percentage consensus was at a similar level.
SLN was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-12-10 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-12-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-14 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-10-08 | Morgan Stanley | Reiterate | Overweight -> Overweight |
| 2024-08-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-16 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-06-28 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-06-28 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-06-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-17 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-05-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-22 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-03-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-14 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-03-14 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-03-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-02-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-01-31 | BMO Capital | Initiate | Outperform |
| 2024-01-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-11-17 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-17 | Chardan Capital | Reiterate | Buy -> Buy |
| 2023-08-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-07-24 | Morgan Stanley | Reiterate | Overweight -> Overweight |
| 2023-07-17 | Morgan Stanley | Reiterate | Overweight -> Overweight |
| 2023-06-26 | Morgan Stanley | Reiterate | Overweight -> Overweight |